Director/PDMR Shareholding
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | 1. Amjad Bseisu 2. The Amjad & Suha Bseisu Foundation |
|||
| 2 | Reason for the notification | ||||
| a) | Position/status | 1. Chief Executive of EnQuest PLC 2. The Amjad & Suha Bseisu Foundation is a registered charity, of which Amjad Bseisu (CEO of EnQuest PLC) is a Trustee. |
|||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | EnQuest PLC | |||
| b) | LEI | 2138008LJU6WFQWOXJ73 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | £0.05 ordinary shares | |||
| Identification code | GB00B635TG28 | ||||
| b) | Nature of the transaction |
1. Amjad Bseisu's EnQuest Nil Cost Share Options granted under the 2018 and 2019 EnQuest Performance Share Plans are being exercised. On completion of the exercise and transfer process, Amjad Bseisu will have the ability to influence voting in respect of the following shareholdings in EnQuest PLC:
|
|||
| c) | Price(s) and volume(s) | ||||
| Price | Volume(s) | ||||
| 1. | £n/a | 4,604,010 | |||
| 2. | £n/a | 4,604,010 | |||
| d) | Aggregated information - Aggregated volume - Price |
n/a | |||
| e) | Date of the transactions | 29 July 2022 | |||
| f) | Place of the transactions | n/a | |||
Ends
For further information please contact:
EnQuest PLC Tel: +44 (0)20 7925 4900
Kate Christ
Acting Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.